Equities

Kinarus Therapeutics Holding AG

Kinarus Therapeutics Holding AG

Actions
  • Price (CHF)6.50
  • Today's Change0.00 / 0.00%
  • Shares traded1.84k
  • 1 Year change-84.23%
  • Beta3.8622
Data delayed at least 15 minutes, as of Jul 03 2024 16:06 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Kinarus Therapeutics Holding AG is a Switzerland-based Company that operates as a biopharmaceutical industry engaged in diseases treatment. The Company conducts its work within clinical-stage area and its activities include discovery, examination and development of medicines that are intended for the treatment of viral, respiratory, and ophthalmic diseases. Kinraus therapeutic drug is patent protected KIN001 which is a combination of pamapimod and pioglitazone. KIN0001 offers oral, long-term treatment of diseases with severe impact on the comfort of living.

  • Revenue in CHF (TTM)0.00
  • Net income in CHF-49.38m
  • Incorporated1997
  • Employees15.00
  • Location
    Kinarus Therapeutics Holding AGTechnologiepark BaselHochbergerstrasse 60CBASEL 4057SwitzerlandCHE
  • Phone+41 616332971
  • Fax+41 445000801
  • Websitehttp://www.kinarus.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sky Blue 11 Co Ltd13.18m-5.37m17.99m42.00------1.36-0.1255-0.12550.3078-0.0080.27680.50961.002,713,572.00-11.28-9.82-197.41-34.2727.6934.45-40.75-22.860.4709-21.552.19---37.0613.42-1,977.24---72.09--
TraWell Co SpA28.42m1.11m18.54m201.0042.572.632.590.65260.1780.1784.622.880.6812.958.81145,554.807.68-2.2213.28-3.5692.4492.9411.28-3.210.6473.810.483--15.82-7.32154.55-10.00-7.74--
SAS AB3.77bn-497.58m19.62m8.30k------0.0052-0.8015-0.80156.07-1.580.771341.416.425,542,279.00-10.18-11.07-21.98-17.8361.4662.35-13.20-18.050.4287-0.43751.34--32.11-1.2319.11---10.11--
Aviation Links Ltd175.17m4.69m23.68m172.005.051.583.200.13522.552.5595.508.152.37--12.13--8.755.2732.2217.7614.1013.833.702.45----0.236--0.74730.9436-2.7058.43-1.35--
Surf Air Mobility Inc77.39m-241.42m28.00m625.00------0.3617-4.33-4.331.36-1.301.40--34.74136,995.20-437.38------9.57---311.94-----2.97----198.44---237.13------
Kinarus Therapeutics Holding AG0.00-49.38m28.51m15.00---------169.12-169.120.00-1.090.00-------697.16-483.12-821.63-658.52-------397.95---241.72---------42.17------
Zeal Global Services Ltd-1.08bn-1.08bn28.81m38.00-------------------------------------------------7.34--27.52------
Fly Play hf254.41m-31.75m30.79m477.00--8.221.810.121-5.64-5.6445.170.3040.6503151.3310.0981,875,120.00-8.12---10.97--73.17---12.48--0.422-1.150.9931--101.41--26.41------
AirAsia Indonesia Tbk PT385.61m-103.64m31.81m1.89k------0.0825-175.92-175.92654.55-812.891.1464.00191.073,646,490,000.00-30.74-33.72----11.5813.05-26.86-41.260.0423-2.48----75.259.3734.46---46.23--
Nigerian Aviation Handling Company Plc18.89m3.83m34.53m1.89k10.815.137.731.833.343.3416.477.041.1729.173.10--23.6911.9947.8720.7055.1543.6520.2613.811.3257.600.059588.2969.9823.78108.4194.3820.4564.90
Sona Topas Tourism Industry Tbk PT40.72m-588.16k34.69m790.00--1.078.300.852-16.10-16.101,115.06887.780.79982.7339.621,009,040,000.00-1.16-3.55-1.43-4.2853.6550.35-1.45-5.463.0117.290.1942--121.99-18.5779.58---12.45--
Knafaim Holdings Ltd25.15m12.93m37.43m3.65k2.890.7029--1.493.303.306.4213.590.1441--7.02--7.05-0.75559.62-1.1831.8934.9148.90-27.02----0.56435.66-5.07-58.24180.33---67.51--
Data as of Jul 03 2024. Currency figures normalised to Kinarus Therapeutics Holding AG's reporting currency: Swiss Franc CHF

Institutional shareholders

0.06%Per cent of shares held by top holders
HolderShares% Held
Credit Suisse Asset Management (Schweiz) AGas of 29 Feb 20242.21k0.05%
Credit Suisse AGas of 31 Jan 2024179.000.00%
UBS Asset Management Switzerland AGas of 28 Mar 202478.000.00%
BlackRock Asset Management Schweiz AGas of 06 Jun 202433.000.00%
State Street Global Advisors France SAas of 31 Mar 20244.000.00%
Z�rcher Kantonalbank (Investment Management)as of 30 Apr 20243.000.00%
Pictet Asset Management SAas of 29 Feb 20241.000.00%
More ▼
Data from 31 Mar 2024 - 27 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.